WHO-appointed Afrigen vaccine consortium looking beyond Covid-19

The MD of Cape Town-based Afrigen Biologics and Vaccines, Prof Petro Terblanche, chats to BizNews in the wake of an announcement by the WHO that its consortium will be one of six tech-transfer hubs established on the continent. These six hubs will be ramping up production of commercially viable vaccines to about one billion doses for the continent, but its focus also will also lie beyond the current pandemic. It will be supporting efforts to increase Covid-19 vaccination rates in Africa, currently as low as 11% having received a single dose. Terblanche says they have created a platform that will allow them to manufacture vaccines for other diseases like HIV/Aids, TB, influenza, and ebola. Learn more about your ad choices. Visit megaphone.fm/adchoices